BRCA1 and Hereditary breast and ovarian cancer syndrome: Two BRCA1 founder mutations (c.5266dupC, and c.4035delA) account for approximately 80% of all detectable BRCA1 and BRCA2 mutations in breast-ovarian cancer families [3–6].